Ownership history in Rathbones Group PLC · 16 quarters on record
This page tracks every 13F SEC filing in which Rathbones Group PLC reported a position in VERONA PHARMA Spon ADR Each Rep 8 Ord Shs (VRNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 2,275 | -4,596 | -66.9% | 0.00% | $243K | — |
| 2025 Q2 | REDUCED | 6,871 | -1,347 | -16.4% | 0.00% | $650K | — |
| 2025 Q1 | REDUCED | 8,218 | -2,000 | -19.6% | 0.00% | $522K | — |
| 2024 Q4 | REDUCED | 10,218 | -1,683 | -14.1% | 0.00% | $475K | — |
| 2024 Q3 | REDUCED | 11,901 | -3,950 | -24.9% | 0.00% | $342K | — |
| 2024 Q2 | REDUCED | 15,851 | -125 | -0.8% | 0.00% | $229K | — |
| 2024 Q1 | UNCHANGED | 15,976 | — | 0% | 0.00% | $257K | — |
| 2023 Q4 | UNCHANGED | 15,976 | — | 0% | 0.00% | $318K | — |
| 2023 Q3 | ADDED | 15,976 | +6,392 | +66.7% | 0.00% | $260K | — |
| 2023 Q2 | REDUCED | 9,584 | -125 | -1.3% | 0.00% | $203K | — |
As of 2025 Q3 — sorted by position size